Correlation Between Kymera Therapeutics and Valneva SE

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Kymera Therapeutics and Valneva SE at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Kymera Therapeutics and Valneva SE into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Kymera Therapeutics and Valneva SE ADR, you can compare the effects of market volatilities on Kymera Therapeutics and Valneva SE and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Kymera Therapeutics with a short position of Valneva SE. Check out your portfolio center. Please also check ongoing floating volatility patterns of Kymera Therapeutics and Valneva SE.

Diversification Opportunities for Kymera Therapeutics and Valneva SE

-0.74
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between Kymera and Valneva is -0.74. Overlapping area represents the amount of risk that can be diversified away by holding Kymera Therapeutics and Valneva SE ADR in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Valneva SE ADR and Kymera Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Kymera Therapeutics are associated (or correlated) with Valneva SE. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Valneva SE ADR has no effect on the direction of Kymera Therapeutics i.e., Kymera Therapeutics and Valneva SE go up and down completely randomly.

Pair Corralation between Kymera Therapeutics and Valneva SE

Given the investment horizon of 90 days Kymera Therapeutics is expected to under-perform the Valneva SE. But the stock apears to be less risky and, when comparing its historical volatility, Kymera Therapeutics is 3.12 times less risky than Valneva SE. The stock trades about -0.3 of its potential returns per unit of risk. The Valneva SE ADR is currently generating about 0.35 of returns per unit of risk over similar time horizon. If you would invest  485.00  in Valneva SE ADR on November 27, 2024 and sell it today you would earn a total of  296.00  from holding Valneva SE ADR or generate 61.03% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

Kymera Therapeutics  vs.  Valneva SE ADR

 Performance 
       Timeline  
Kymera Therapeutics 

Risk-Adjusted Performance

Very Weak

 
Weak
 
Strong
Over the last 90 days Kymera Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. Even with weak performance in the last few months, the Stock's primary indicators remain relatively invariable which may send shares a bit higher in March 2025. The latest agitation may also be a sign of long-running up-swing for the enterprise retail investors.
Valneva SE ADR 

Risk-Adjusted Performance

Solid

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in Valneva SE ADR are ranked lower than 18 (%) of all global equities and portfolios over the last 90 days. In spite of very uncertain essential indicators, Valneva SE displayed solid returns over the last few months and may actually be approaching a breakup point.

Kymera Therapeutics and Valneva SE Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Kymera Therapeutics and Valneva SE

The main advantage of trading using opposite Kymera Therapeutics and Valneva SE positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Kymera Therapeutics position performs unexpectedly, Valneva SE can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Valneva SE will offset losses from the drop in Valneva SE's long position.
The idea behind Kymera Therapeutics and Valneva SE ADR pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Stock Screener module to find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook..

Other Complementary Tools

Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments